High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma

High metabolic tumor volume (MTV) predicts worse outcomes in lymphoma treated with chemotherapy. However, it is unknown if this holds for patients treated with axicabtagene ciloleucel (axi-cel), an anti-CD19 targeted chimeric antigen receptor T-cell therapy. The primary objective of this retrospecti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Dean, Erin A., Mhaskar, Rahul S., Lu, Hong, Mousa, Mina S., Krivenko, Gabriel S., Lazaryan, Aleksandr, Bachmeier, Christina A., Chavez, Julio C., Nishihori, Taiga, Davila, Marco L., Khimani, Farhad, Liu, Hien D., Pinilla-Ibarz, Javier, Shah, Bijal D., Jain, Michael D., Balagurunathan, Yoganand, Locke, Frederick L.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2020
Assuntos:
Lymphoid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7391155/
https://ncbi.nlm.nih.gov/pubmed/32702097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001900
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados